In Merkel cell carcinoma, exosomal miR-375 reprograms fibroblasts by targeting RBPJ/TP53, fostering a pro-metastatic niche [22], and in ER-positive breast cancer, it sustains ERα activity by downregulating RASD1 [23]. This evidence concerns the gene RASD1 and Merkel cell skin cancer.